These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31478094)

  • 41. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.
    Martínez-Ortega JM; Funes-Godoy S; Díaz-Atienza F; Gutiérrez-Rojas L; Pérez-Costillas L; Gurpegui M
    Eur Child Adolesc Psychiatry; 2013 Aug; 22(8):457-79. PubMed ID: 23503976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement.
    Lambert TJ; Chapman LH;
    Med J Aust; 2004 Nov; 181(10):544-8. PubMed ID: 15540966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal.
    Alvarez-Jiménez M; González-Blanch C; Crespo-Facorro B; Hetrick S; Rodríguez-Sánchez JM; Pérez-Iglesias R; Vázquez-Barquero JL
    CNS Drugs; 2008; 22(7):547-62. PubMed ID: 18547125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study.
    Galbally M; Frayne J; Watson SJ; Morgan V; Snellen M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):63-69. PubMed ID: 31141172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis.
    Curtis J; Watkins A; Rosenbaum S; Teasdale S; Kalucy M; Samaras K; Ward PB
    Early Interv Psychiatry; 2016 Jun; 10(3):267-76. PubMed ID: 25721464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study.
    Mitchell AJ; Vancampfort D; Manu P; Correll CU; Wampers M; van Winkel R; Yu W; De Hert M
    PLoS One; 2019; 14(9):e0210674. PubMed ID: 31513598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
    Perez-Iglesias R; Vazquez-Barquero JL; Amado JA; Berja A; Garcia-Unzueta MT; Pelayo-Terán JM; Carrasco-Marín E; Mata I; Crespo-Facorro B
    J Clin Psychopharmacol; 2008 Jun; 28(3):289-95. PubMed ID: 18480685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Psychotropic drugs and diabetes].
    Ress C; Tschoner A; Kaser S; Ebenbichler CF
    Wien Med Wochenschr; 2011 Nov; 161(21-22):531-42. PubMed ID: 21792529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.
    Garriga M; Fernandez-Egea E; Mallorqui A; Serrano L; Oliveira C; Parellada E; Kirkpatrick B; Vieta E; Bernardo M; Garcia-Rizo C
    J Psychiatr Res; 2019 Aug; 115():29-35. PubMed ID: 31085376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.
    Chue P; Kovacs CS
    Bipolar Disord; 2003; 5 Suppl 2():62-79. PubMed ID: 14700015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies.
    Burghardt KJ; Seyoum B; Mallisho A; Burghardt PR; Kowluru RA; Yi Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():55-63. PubMed ID: 29325867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review.
    Britvic D; Maric NP; Doknic M; Pekic S; Andric S; Jasovic-Gasic M; Popovic V
    Psychiatr Danub; 2013 Dec; 25(4):410-5. PubMed ID: 24247054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of first and second-generation antipsychotic drugs and the potential to develop gestational diabetes mellitus among perinatal patients with psychosis.
    Kulkarni J; Gurvich C; Gilbert H; Worsley R; Li Q; Karimi L
    Schizophr Res; 2023 Apr; 254():22-26. PubMed ID: 36758325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment with antipsychotics and the risk of diabetes in clinical practice.
    Kessing LV; Thomsen AF; Mogensen UB; Andersen PK
    Br J Psychiatry; 2010 Oct; 197(4):266-71. PubMed ID: 20884948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis.
    Suetani S; Siskind D; Phillipou A; Waterreus A; Morgan VA; Castle D
    Aust N Z J Psychiatry; 2021 Oct; 55(10):958-975. PubMed ID: 33906481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
    Pandit R; Cianci D; Ter Hark SE; Winter-van Rossum I; Ebdrup BH; Broberg BV; Garcia-Portilla MP; Bobes J; Vinkers CH; Kahn RS; Guloksuz S; Huitema ADR; Luykx JJ
    Acta Psychiatr Scand; 2019 Sep; 140(3):283-290. PubMed ID: 31323113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.